Navigation Links
Ambrilia Highlights Encouraging Data for its HIV Integrase,Inhibitor Program and Recent Developments at Annual Meeting

MONTREAL, QUEBEC--(CCNMatthews - June 14, 2007) - Ambrilia Biopharma Inc. (TSX:AMB), a biopharmaceutical company developing novel small molecules and peptides to treat infectious diseases and cancer, held its Annual General and Special Meeting today, during which the data reported yesterday on its novel series of HIV integrase inhibitors and recent developments were highlighted. The meeting was chaired by the new Chairman of the Board, Mr. Frederic Porte, and a progress report was presented by Mrs. Monique Letourneau, Executive Vice-President, Finance and Chief Financial Officer, followed by a scientific review presented by Dr. Bonabes de Rouge, Senior Executive Vice-President and Chief Scientific Officer.

"I would like to reiterate that the Board is committed to the success of Ambrilia. I look forward to guiding the Company as it continues to make advances in its key programs, and our productive relationship with Merck in the development of PPL-100", said Frederic Porte, Chairman of the Board of Ambrilia. "We are well advanced in the process of looking at strategic options for the Company and I believe this will enable us to be more focused as we move forward. Within the next number of months and even on into next year, our priorities will be the development of the HIV Integrase Program while bringing Octreotide and Goserelin closer to market", he concluded.

RECENT HIGHLIGHTS

- Ambrilia's novel series of HIV integrase inhibitors were presented at the prestigious XVI International HIV Drug Resistance Workshop. These preclinical data showed their potential distinct mechanism of action, which may lead to a different resistance profile from known integrase inhibitors currently in clinical development by pharmaceutical companies. The Company is now accelerating its HIV Integrase Inhibitor Program and aims to have a drug candidate within the next 12 months.

- Co-abstract on the structural
'"/>




Page: 1 2 3 4

Related medicine technology :

1. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
2. BusinessWeek Article Highlights Promising Breakthrough Treatment for Advanced Coronary Artery Disease
3. Expert Opinion Highlights Avigens AV411 as Potential New Therapeutic for Neuropathic Pain and Opioid Withdrawal
4. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
5. July Issue of Journal of Antimicrobial Chemotherapy Highlights Study of Factive Tablets for Five-Day Treatment of Community-Acquired Pneumonia
6. Inovio Biomedical Highlights Enhanced DNA Vaccine Potency with Electroporation DNA Delivery Technology and New Devices at Gene Therapy Meeting
7. Presentations at 2007 European Stroke Congress Highlights New Direction for Viprinex (ancrod)
8. Data to be Presented at ASCO 2007 Highlights sanofi-aventis Commitment to Cancer Care and Research
9. MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations
10. New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
11. New Data Highlights Potential of SPP100 (Tekturna) as Gold Standard Therapy in Treatment of Hypertension

Post Your Comments:
(Date:11/19/2009)..., , LOVELAND, Colo., Nov. 19 /PRNewswire-...hance its customers, experience, Heska Corporation...nced today the launch of its new and improved webs...onths of analysis, design and programming to align...trategic objectives. ,, (Logo: http://www.ne...
(Date:11/19/2009)..., , MOUNTAIN VIEW, Calif., Nov. 19 /PRNewsw...sdaq: ALXA ) announced today that its corporate p...nnual Piper Jaffray Health Care Conference on Wedn... The presentation will be webcast from The New Yo...by Thomas B. King, Alexza President and CEO. ,...
(Date:11/19/2009)..., , ABBOTT PARK, Ill., Nov. 19 /PRNewswire...bbott (NYSE: ABT ) as one of its Most Admired Co.... The Deal honored Abbott as its Most Admired D...strategic use of acquisitions and divestitures sin...t has reshaped its business portfolio with a focus...
Breaking Medicine Technology:Heska Announces Launch of New Website 2Heska Announces Launch of New Website 3Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 2Alexza Pharmaceuticals to Present at the 21st Annual Piper Jaffray Health Care Conference 3The Deal Names Abbott Top Dealmaker for Second Consecutive Year 2The Deal Names Abbott Top Dealmaker for Second Consecutive Year 3Mom 26 Baby Mobile Health Centers Have Become Primary Care Providers Along the Gulf Coast 55092 1Mom 26 Baby Mobile Health Centers Have Become Primary Care Providers Along the Gulf Coast 55092 2Mom 26 Baby Mobile Health Centers Have Become Primary Care Providers Along the Gulf Coast 55092 3New technique can help diagnose mesothelioma 55087 1New technique can help diagnose mesothelioma 55087 2U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 1U M researchers discover therapeutic target that could help patients with pulmonary fibrosis 55083 2
...URG, Germany, June 2 "A two-year,survival rate of...naplastic,astrocytoma suggests a breakthrough in t...ented Prof. Ulrich Bogdahn, Neuro-Oncologist and C...ontrolled dose-finding trial with AP,12009 in recu...nting the,data at the 44th Annual Meeting of the A...
...Perifosine in the Treatment of Patients with Rela... be presented Tomorrow, Tuesday, June 3rd...x Biopharmaceuticals,Inc. (Nasdaq: KERX ) today a...osine) have been selected for both poster presenta...f Clinical Oncology Meeting,currently taking place...
Other Medicine Technology:Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 2Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 3Clinical Proof of Concept for TGF-beta 2-Inhibitor AP 12009 in Phase Iib EMEA provides Guidance on Phase III Design and Approval Requirements 4Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 2Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 3Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 4Keryx Biopharmaceuticals, Inc. Announces Poster Presentation Highlighting Observed Clinical Activity of KRX-0401 (Perifosine) at the American Society of Clinical Oncology Meeting in Chicago, Illinois 5
(Date:11/20/2009)...ut of Dallas, TX, the new addition to blue sky scr... made in the USA. , Austi... is an independent medical scrubs brand which focu...nd distribution of hospital uniforms and surgical ... via their online boutique, the Austin, TX busines...
(Date:11/20/2009)...ying 90-day supply, study finds , , FRID...th supply of prescription drugs is up to one-third... to a new study. , U.S. researchers analyzed 26...00 and 2005, and found that patients who bought a ...aved an average 29 percent in out-of-pocket costs....
(Date:11/20/2009)...d is expected to continue, CDC says, , ,...f the United States are seeing declines in H1N1 sw...riday, and while the disease remains widespread in...d last week. , "We are beginning to see some de...ut there is still a lot of influenza everywhere," ...
(Date:11/20/2009)...esses increased food insecurity as many face probl...Newswire/ -- Project Bread, the state,s leading an...upcoming annual status report on hunger in the Com...s report, caused by high unemployment, point to 55...unger. Food insecurity has found its way into midd...
(Date:11/20/2009)...f., Nov. 20 Omnicell, In...olutions to acute healthcare facilities, announced...l Piper Jaffray Healthcare Conference at the New ... Speakers: Randall A. Lipps, founder, chairman, p...mp; CFO ,, Date: Tuesday, December 1, 2009 ,...
Breaking Medicine News(10 mins):Health News:Blue Sky Scrubs Secures a Second Texas Manufacturer 2Health News:Three-Month Supply Lowers Drug Costs 2Health News:Swine Flu Declining in Some Parts of U.S. 2Health News:Swine Flu Declining in Some Parts of U.S. 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 2Health News:554,000 in Massachusetts Struggle to Put Food on the Table 3Health News:554,000 in Massachusetts Struggle to Put Food on the Table 4Health News:Omnicell to Present at Piper Jaffray Healthcare Conference 2
...ties join Healthy Kids Dental July 1, LANSING, Mi...lm and the Michigan Department of Community Health...s Healthy Kids Dental program to,include 80,000 ch...ct July 1, 2008., "We are extending needed health...
...te Vote to Block Medicare Improvement Bill, Bipar...vention, Mental,Health and Low-Income Programs, Bo...TIMORE, June 12 The following was issued,today by...ns,who depend on it. The Medicare Improvements for...
... fewer complaints of insomnia predicted a healthie...(HealthDay News) -- Normal sleep is associated wit...at the University of California, San Diego assesse...ty, and sleep duration. Based on the results, 20.8...
...ight Watchers,International, Inc. (NYSE: WTW ) to... its quarterly cash dividend of $0.175 per share, ....70 per share. This quarterly dividend will,be pay...rs International, Inc. is the world,s leading prov...
...er Clinics of Excellence (CCE), the,nation,s only ...munity,oncologists has announced its management sl... J. Ike Nicoll is President/COO of CCE. Most,recen...rman had previously served as CCE,s Chief Quality,...
...f the body,s genetic and molecular machinery is po...stom-designed for each individual. But this emergi...aim to prescribe the right medicine in the right a...rican Association for the Advancement of Science a...
Other Medicine News:Health News:Dental Services Expand to Serve More Than 280,000 Michigan Children 2Health News:AARP Maryland Key Vote News Alert 2Health News:AARP Maryland Key Vote News Alert 3Health News:Better Sleepers Are 'Successful Agers' 2Health News:Weight Watchers Declares Quarterly Dividend 2Health News:Cancer Clinics of Excellence (CCE) Announces Management and Board of Directors Slate at 1st Annual General Membership Meeting 2Health News:AAAS hosts June 20 conference on personalized medicine 2
...creases therapy versatility with faster programmin... cardiac output. The InSync III system also offers...ostics and monitoring trends, to efficiently track...edtronic offers cardiac resynchronization systems ...
...und system is the most advanced and versatile high...HF35-50 allows users to perform high frequency ult... 35MHz or 50MHz probes or high resolution posterio... , ,The Macintosh computer provides for image ...
...und system is the most advanced and versatile high...HF35-50 allows users to perform high frequency ult... 35MHz or 50MHz probes or high resolution posterio... , ,The Macintosh computer provides for image ...
...l A-scan system which provides easy-to-use touch s...cy, low noise probe and fast precise algorithm ena...the probe along the visual axis. The PacScan 300A ...ent user profiles, 5 different examination modes, ...
Medicine Products: